GlassScriptPhysician profile
Brock Hollett
NPI 1528475324
$1,707.74
in general payments reported to CMS, 2019-2025
17 companies · $15.72 in 2025
The $15.72 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $103 · 2021: $184 · 2022: $305 · 2023: $232 · 2024: $51.65 · 2025: $15.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $407.58 | 2019-2025 | Invega Trinza, Invega Sustenna, Spravato |
| Sunovion Pharmaceuticals INC. | $355.14 | 2019-2021 | |
| Abbvie INC. | $157.03 | 2021-2023 | |
| Indivior INC. | $128.89 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $105.95 | 2022-2023 | Ingrezza |
| Avanir Pharmaceuticals, INC. | $82.22 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $78.92 | 2019 | |
| Allergan, INC. | $69.71 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.43 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $55.62 | 2021-2023 | |
| Napo Pharmaceuticals INC | $42.64 | 2019 | |
| Alkermes, INC. | $39.53 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $39.41 | 2020 | |
| Tempus Ai, INC | $28.39 | 2024 | |
| Janssen Biotech, INC. | $25.57 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $19.21 | 2019 | |
| Shire North American Group INC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Hollett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.